Special warnings and precautions for use
Betahistine dihydrochloride is considered to be unsafe in patients with porphyria
Betahistine dihydrochloride should be administered with caution to patients with bronchial asthma (due to clinical intolerance) or a history of peptic ulcer.
Betahistine dihydrochloride is not recommended for use in children.
Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Effects on ability to drive and use machines
Vertigo, tinnitus and hearing loss associated with Ménière's syndrome can negatively affect the ability to drive and use machines. In clinical studies specifically designed to investigate the ability to drive and use machines betahistine had no or negligible effects.
List of excipients
Povidone K90
Microcrystalline cellulose
Lactose monohydrate
Colloidal anhydrous silica
Crospovidone
Stearic acid
Special precautions for storage
Do not store above 25° C. Store in the original package. Keep container in the outer carton.
Nature and contents of container
Blister strips consisting of 250 µm transparent PVC, a 60 g/m2 PVDC layer and 20µm hard temper aluminium foil, contained in a carton.
Pack sizes: 60, 84, 90, 100 and 120 tablets.